Tissue-specific restriction of latent turkey HVT transcription

Acta Virologica

Volumn 43, Issue 2-3, 1999, Pages 148-151

  Holland, M S ^a   Silva, R F ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

HVT; Latency; Tissue tropism; Transcription

Indexed keywords

VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRACHIAL PLEXUS; HERPES VIRUS; LYMPHOID CELL; NONHUMAN; NUCLEOTIDE REPEAT; PROTEIN EXPRESSION; SCIATIC NERVE; SPLEEN; THYMUS; TISSUE SPECIFICITY; TURKEY (BIRD); VIRUS INFECTION; VIRUS ISOLATION; VIRUS TRANSCRIPTION;

ANIMALS; CHICKENS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GAMMAHERPESVIRINAE; GENOME, VIRAL; HERPESVIRIDAE INFECTIONS; IN SITU HYBRIDIZATION; NERVE TISSUE; ORGAN SPECIFICITY; POULTRY DISEASES; RNA, VIRAL; SPLEEN; THYMUS GLAND; TRANSCRIPTION, GENETIC; TURKEYS; VIRAL PROTEINS; VIRUS LATENCY;

ANIMALIA; AVES; DNA VIRUSES; GALLUS GALLUS; HERPES; HERPESVIRIDAE; MELEAGRID HERPESVIRUS 1; MELEAGRIS GALLOPAVO;

EID: 0033033480     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Buscaglia C, Calnek BW, Schat KA (1983): Effect of immunocompetence on the establishment and maintenance of latency with Marek's disease herpesvirus. J. Gen. Virol. 69, 1067-1077.
2. Calnek BW, Shek WR, Schat KA (1981): Latent infections with Marek's disease virus and turkey herpesvirus. J. Natl. Can. Inst. 66, 585-590.
3. Cantello JL, Anderson AS, Morgan RW (1994): Identification of latency-associated transcripts that map antisense to the ICP4 homolog gene of Marek's disease virus. J. Virol. 68, 6280-6290.
4. Deatley AM, Spivak JG, Lavi E, Fraser NW (1987): RNA from an immediate early region of the type 1 herpes simplex virus genome is present in the trigeminal ganglia of latently infected mice. Proc. Natl. Acad. Sci. USA 84, 3204-3208.
5. Doerig C, Pizer LI, Wilcox CL (1991): Detection of the latency-associated transcript in neuronal cultures during the latent infection with herpes simplex virus type 1. Virology 183, 423-426.
6. Gregory CD, Rowe M, Rickinson AB (1990): Different Epstein-Barr virus B cell interactions in phenotypically distinct clones of a Burkitt lymphoma cell line. J. Gen. Virol. 71, 1481-1485.
7. Holland MS, Mackenzie, CD, Bull RW, Silva RF (1996): A comparative study of histological conditions suitable for both immunofluorescence and in situ hybridization in the detection of herpesvirus and its antigens in tissues of chickens. J. Histochem. Cytochem. 44, 259-265.
8. Holland MS, Mackenzie CD, Bull RW, Silva RF (1998): Latent turkey herpesvirus infection in lymphoid, nervous, and feather tissues of chickens. Avian. Dis. 42, 292-299.
9. Kieff E, Liebowitz D (1990): Epstein-Barr virus and its replication. In Fields BN, Knipe DM et al. (Eds): Field's Virology. Raven Press, New York, pp. 1889-1920.
10. Lear AL, Rowe M, Kurilla MG, Lee S, Henderson S, Kieff E, Rickinson AB (1992): The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle. J. Virol. 66, 7461-7468.
11. Puga A, Notkins AL (1987): Continued expression of a poly(A)+ transcript of herpes simplex virus type 1 in trigeminal ganglia of latently infected mice. J. Virol. 61, 1700-1703.
12. Rock DL, Beam SL, Mayfield JE (1987): Mapping bovine herpesvirus type 1 latency-related RNA in trigeminal ganglia of latently infected rabbits. J. Virol. 61, 3827-3831.
13. Rock DL (1993): The molecular basis of latent infections by alphaherpesviruses. Semin. Virol. 4, 157-165.
14. Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H, Rickinson AB (1987): Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J. 6, 2743-2751
15. Shek WR, Calnek BW, Schat KA, Chen C-LH (1983): Characterization of Marek's disease virus-infected lymphocytes: discrimination between cytolytically and latently infected cells. J. Natl. Can. Inst. 70, 485-491.
16. Steiner I, Kennedy PG (1991): Hypothesis: Herpes simplex virus latency in the nervous system - a new model. Neuropathol. Appl. Neurobiol. 17, 433-440.
17. Stevens JG, Wagner EK, Devi-Rao GB, Cook ML, Feldman LT (1987): RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science 235, 1056-1059.
18. Wilcox CL Johnson EM (1988): Characterization of nerve growth factor-dependent herpes simplex virus latency in neurons in vitro. J. Virol. 62, 393-399.
19. Wilcox CL, Smith RL, Freed CR, Johnson EM (1990): Nerve growth factor dependence of herpes simplex virus latency in peripheral sympathetic and sensory neurons in vitro. J. Neurosci. 10, 1268-1275.
20. Witter RL, Solomon JJ, Burgoyne GH (1969): Cell culture techniques for primary isolation of Marek's disease-associated herpesvirus. Avion Dis. 13, 101-118.
21. Witter RL, Solomon JJ, Champion LR, Nazerian K (1971): Longterm studies of Marek's disease infection in individual chickens. Avion Dis. 15, 346-365.
22. Woisetschlaeger M, Yandava CN, Speck SH (1989): Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytes. Proc. Natl. Acad. Sci. USA 86, 6498-6502.
23. Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, Johnson A, Rickinson AB (1988): Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J. Gen. Virol. 69, 1051-1065.